Ambulatory Electrocardiographic Monitoring for the Detection of High-Degree Atrio-Ventricular Block in Patients With New-onset PeRsistent LEft Bundle Branch Block After Transcatheter Aortic Valve Implantation. The MARE Study

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to determine the incidence and predictors of high degree or complete atrioventricular block (AVB) (paroxysmal or persistent) in patients with new-onset persistent left bundle branch block (NOP-LBBB) following transcatheter aortic valve implantation (TAVI) and to evaluate the usefulness of the Reveal LINQ® insertable Cardiac Monitor (ICM) (Medtronic, Inc., Minneapolis, USA) for the detection of significant arrhythmias in patients with NOP-LBBB following TAVI.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Patients undergoing TAVI with either balloon or self-expandable valves who develop new-onset LBBB persistent at hospital discharge, at least 3 days after the procedure

Locations
Other Locations
Canada
IUCPQ
RECRUITING
Québec
Time Frame
Start Date: 2014-01
Estimated Completion Date: 2024-07
Participants
Target number of participants: 80
Treatments
Experimental: Implantable loop recorders Reveal ICM LINQ®,
Sponsors
Leads: Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec

This content was sourced from clinicaltrials.gov

Similar Clinical Trials